|
|
positive regulation of nuclear transcribed mrna poly a tail shortening
|
GO:0060213 |
4 |
0.741
|
Human |
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.627
|
|
|
|
regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0043618 |
8 |
0.574
|
|
|
|
negative regulation of protein kinase activity by regulation of protein phosphorylation
|
GO:0044387 |
2 |
0.548
|
|
|
|
cellular response to calcium ion
|
GO:0071277 |
14 |
0.541
|
|
|
|
regulation of ovulation
|
GO:0060278 |
3 |
0.527
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.507
|
Human |
|
|
gene silencing by mirna
|
GO:0035195 |
10 |
0.472
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.461
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.461
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.456
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.444
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.431
|
Human |
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.417
|
|
|
|
regulation of cyclin dependent protein serine threonine kinase activity involved in g2 m transition of mitotic cell cycle
|
GO:0031660 |
1 |
0.405
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.395
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.376
|
|
|
|
negative regulation of respiratory burst involved in inflammatory response
|
GO:0060266 |
1 |
0.375
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.371
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.364
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.357
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.335
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.320
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.317
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.313
|
|
|
|
vitellogenesis
|
GO:0007296 |
2 |
0.308
|
|
|
|
regulation of microvillus assembly
|
GO:0032534 |
3 |
0.306
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.304
|
|
|
|
positive regulation of transcription from rna polymerase i promoter
|
GO:0045943 |
3 |
0.300
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.283
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.276
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0097201 |
1 |
0.275
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.265
|
|
|
|
positive regulation of transforming growth factor beta2 production
|
GO:0032915 |
2 |
0.263
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.261
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.260
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.258
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.258
|
|
|
|
regulation of fibroblast proliferation
|
GO:0048145 |
34 |
0.254
|
|
|
|
regulation of dna templated transcription in response to stress
|
GO:0043620 |
9 |
0.251
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.237
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.231
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.228
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.227
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.216
|
|
|
|
microglial cell activation
|
GO:0001774 |
3 |
0.211
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.210
|
|
|
|
regulation of respiratory burst involved in inflammatory response
|
GO:0060264 |
2 |
0.209
|
|
|
|
regulation of transforming growth factor beta2 production
|
GO:0032909 |
2 |
0.209
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.208
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.206
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.205
|
Human |
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.204
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.204
|
|
|
|
negative regulation of map kinase activity
|
GO:0043407 |
34 |
0.202
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.200
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.198
|
|
|
|
regulation of microvillus organization
|
GO:0032530 |
3 |
0.194
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.192
|
Human |
|
|
osteoclast differentiation
|
GO:0030316 |
62 |
0.183
|
|
|
|
mrna 3 end processing
|
GO:0031124 |
16 |
0.181
|
Human |
|
|
transforming growth factor beta2 production
|
GO:0032906 |
2 |
0.179
|
|
|
|
nuclear transcribed mrna poly a tail shortening
|
GO:0000289 |
7 |
0.176
|
Human |
|
|
regulation of respiratory burst
|
GO:0060263 |
2 |
0.176
|
|
|
|
adrenal cortex formation
|
GO:0035802 |
2 |
0.173
|
|
|
|
positive regulation of mrna catabolic process
|
GO:0061014 |
5 |
0.172
|
Human |
|
|
nuclear transcribed mrna catabolic process deadenylation dependent decay
|
GO:0000288 |
12 |
0.172
|
Human |
|
|
positive regulation of osteoclast differentiation
|
GO:0045672 |
15 |
0.171
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.166
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.160
|
|
|
|
regulation of brown fat cell differentiation
|
GO:0090335 |
5 |
0.158
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.155
|
|
|
|
cellular response to gamma radiation
|
GO:0071480 |
4 |
0.155
|
|
|
|
positive regulation of mrna 3 end processing
|
GO:0031442 |
5 |
0.154
|
Human |
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.151
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.149
|
Human |
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.147
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.147
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.146
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.145
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.143
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.143
|
|
|
|
rna 3 end processing
|
GO:0031123 |
20 |
0.143
|
Human |
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.142
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.141
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.139
|
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.139
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.138
|
|
|
|
cardiac muscle hypertrophy in response to stress
|
GO:0014898 |
10 |
0.138
|
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.133
|
|
|
|
negative regulation of protein serine threonine kinase activity
|
GO:0071901 |
49 |
0.132
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.132
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.130
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.128
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.126
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.123
|
|
|
|
positive regulation of myeloid leukocyte differentiation
|
GO:0002763 |
26 |
0.122
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.121
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.120
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.119
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.119
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.117
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.117
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.116
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.115
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.115
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.114
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.114
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.114
|
|
|
|
axon regeneration
|
GO:0031103 |
12 |
0.113
|
|
|
|
glomerular visceral epithelial cell differentiation
|
GO:0072112 |
10 |
0.112
|
|
|
|
regulation of nuclear transcribed mrna poly a tail shortening
|
GO:0060211 |
4 |
0.111
|
Human |
|
|
neuron death
|
GO:0070997 |
154 |
0.110
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.109
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.109
|
|
|
|
labyrinthine layer development
|
GO:0060711 |
49 |
0.108
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.107
|
|
|
|
embryonic process involved in female pregnancy
|
GO:0060136 |
7 |
0.105
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.105
|
|
|
|
renal filtration cell differentiation
|
GO:0061318 |
10 |
0.105
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.105
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.104
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.101
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.099
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.099
|
|
|
|
central nervous system neuron development
|
GO:0021954 |
67 |
0.099
|
|
|
|
central nervous system segmentation
|
GO:0035283 |
3 |
0.097
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.095
|
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.095
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.095
|
|
|
|
fibroblast proliferation
|
GO:0048144 |
35 |
0.094
|
|
|
|
negative regulation of myeloid cell differentiation
|
GO:0045638 |
38 |
0.094
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.092
|
Human |
|
|
cardiac muscle hypertrophy
|
GO:0003300 |
23 |
0.092
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.091
|
|
|
|
posttranscriptional gene silencing
|
GO:0016441 |
10 |
0.091
|
|
|
|
brown fat cell differentiation
|
GO:0050873 |
36 |
0.090
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.090
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.089
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.089
|
|
|
|
mrna catabolic process
|
GO:0006402 |
22 |
0.089
|
Human |
|
|
positive regulation of fibroblast proliferation
|
GO:0048146 |
20 |
0.088
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.088
|
|
|
|
positive regulation of chromatin modification
|
GO:1903310 |
28 |
0.087
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.087
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.086
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.086
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.085
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.083
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.082
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.082
|
|
|
|
visceral serous pericardium development
|
GO:0061032 |
2 |
0.081
|
|
|
|
nerve development
|
GO:0021675 |
67 |
0.081
|
|
|
|
labyrinthine layer blood vessel development
|
GO:0060716 |
21 |
0.081
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.081
|
|
|
|
negative regulation of ovulation
|
GO:0060280 |
1 |
0.080
|
|
|
|
negative regulation of stem cell differentiation
|
GO:2000737 |
14 |
0.079
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.079
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.079
|
Human |
|
|
dendrite development
|
GO:0016358 |
115 |
0.079
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.078
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.078
|
|
|
|
general adaptation syndrome
|
GO:0051866 |
2 |
0.078
|
|
|
|
hexose transport
|
GO:0008645 |
56 |
0.077
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.077
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.076
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.076
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.074
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.074
|
Human |
|
|
response to calcium ion
|
GO:0051592 |
20 |
0.074
|
|
|
|
vestibular reflex
|
GO:0060005 |
4 |
0.074
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.074
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.074
|
Human |
|
|
monosaccharide biosynthetic process
|
GO:0046364 |
44 |
0.073
|
|
|
|
neuron projection regeneration
|
GO:0031102 |
14 |
0.073
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.072
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.072
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.072
|
|
|
|
post embryonic camera type eye development
|
GO:0031077 |
8 |
0.072
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.072
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.071
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.070
|
|
|
|
regulation of antimicrobial humoral response
|
GO:0002759 |
3 |
0.070
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.069
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.068
|
|
|
|
regulation of translation
|
GO:0006417 |
71 |
0.068
|
Human |
|
|
mrna processing
|
GO:0006397 |
63 |
0.067
|
Human |
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.067
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.067
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.067
|
|
|
|
rhombomere 5 development
|
GO:0021571 |
4 |
0.067
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.067
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.066
|
|
|
|
positive regulation of protein deacetylation
|
GO:0090312 |
9 |
0.066
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.065
|
|
|
|
positive regulation of neuron apoptotic process
|
GO:0043525 |
25 |
0.065
|
|
|
|
negative regulation of fat cell differentiation
|
GO:0045599 |
36 |
0.065
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.064
|
|
|
|
negative regulation of blood vessel endothelial cell migration
|
GO:0043537 |
3 |
0.064
|
|
|
|
sperm motility
|
GO:0030317 |
47 |
0.064
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.064
|
|
|
|
regulation of endothelial cell proliferation
|
GO:0001936 |
23 |
0.064
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.064
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.064
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.063
|
|
|
|
glomerulus development
|
GO:0032835 |
40 |
0.063
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.062
|
|
|
|
macrophage activation
|
GO:0042116 |
27 |
0.062
|
|
|
|
regulation of mrna stability
|
GO:0043488 |
23 |
0.062
|
|
|
|
erythrocyte maturation
|
GO:0043249 |
6 |
0.062
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.062
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.062
|
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.061
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.061
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.060
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.060
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.060
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.059
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.059
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.059
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.059
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.058
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.058
|
|
|
|
regulation of mrna 3 end processing
|
GO:0031440 |
6 |
0.058
|
Human |
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.058
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.058
|
|
|
|
adrenal cortex development
|
GO:0035801 |
2 |
0.058
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.057
|
|
|
|
cellular response to follicle stimulating hormone stimulus
|
GO:0071372 |
1 |
0.057
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.057
|
|
|
|
3 utr mediated mrna stabilization
|
GO:0070935 |
2 |
0.056
|
|
|
|
endothelial cell proliferation
|
GO:0001935 |
27 |
0.056
|
|
|
|
striated muscle hypertrophy
|
GO:0014897 |
24 |
0.056
|
|
|
|
rhombomere morphogenesis
|
GO:0021593 |
2 |
0.056
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.055
|
|
|
|
blastocyst formation
|
GO:0001825 |
33 |
0.055
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.055
|
|
|
|
posttranscriptional gene silencing by rna
|
GO:0035194 |
10 |
0.055
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.054
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.054
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
64 |
0.054
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.054
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.053
|
|
|
|
negative regulation of mapk cascade
|
GO:0043409 |
65 |
0.053
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.053
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.053
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.053
|
|
|
|
regulation of dopamine metabolic process
|
GO:0042053 |
10 |
0.052
|
|
|
|
glomerular epithelial cell differentiation
|
GO:0072311 |
10 |
0.052
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.052
|
|
|
|
facial nerve morphogenesis
|
GO:0021610 |
11 |
0.052
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.052
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.052
|
|
|
|
associative learning
|
GO:0008306 |
61 |
0.052
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.051
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.051
|
|
|
|
regulation of leukocyte apoptotic process
|
GO:2000106 |
56 |
0.051
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.051
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.051
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.051
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.051
|
Human |
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.051
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.050
|
|
|
|
regulation of heart growth
|
GO:0060420 |
31 |
0.050
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.050
|
|
|
|
regulation of transcription from rna polymerase ii promoter in response to hypoxia
|
GO:0061418 |
2 |
0.050
|
|
|
|
cellular response to antibiotic
|
GO:0071236 |
4 |
0.050
|
|
|
|
regulation of protein autophosphorylation
|
GO:0031952 |
8 |
0.050
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.049
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.049
|
|
|
|
negative regulation of insulin secretion involved in cellular response to glucose stimulus
|
GO:0061179 |
4 |
0.048
|
|
|
|
monosaccharide transport
|
GO:0015749 |
58 |
0.048
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.048
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.048
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.048
|
|
|
|
rhombomere formation
|
GO:0021594 |
1 |
0.048
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.047
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.047
|
|
|
|
protein autophosphorylation
|
GO:0046777 |
61 |
0.047
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.047
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.047
|
|
|
|
rhombomere 5 morphogenesis
|
GO:0021664 |
1 |
0.047
|
|
|
|
response to endoplasmic reticulum stress
|
GO:0034976 |
53 |
0.047
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.047
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.046
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.046
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.046
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.046
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0036003 |
3 |
0.046
|
|
|
|
response to hydrogen peroxide
|
GO:0042542 |
32 |
0.045
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.045
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.045
|
|
|
|
multicellular organismal response to stress
|
GO:0033555 |
62 |
0.045
|
|
|
|
chorio allantoic fusion
|
GO:0060710 |
8 |
0.045
|
|
|
|
histone deacetylation
|
GO:0016575 |
26 |
0.045
|
|
|
|
muscle adaptation
|
GO:0043500 |
39 |
0.044
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.044
|
Human |
|
|
protein acylation
|
GO:0043543 |
64 |
0.044
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.044
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.044
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.044
|
|
|
|
monocyte differentiation
|
GO:0030224 |
9 |
0.044
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.043
|
|
|
|
central nervous system projection neuron axonogenesis
|
GO:0021952 |
21 |
0.043
|
|
|
|
lung cell differentiation
|
GO:0060479 |
30 |
0.043
|
|
|
|
negative regulation of metanephric glomerulus development
|
GO:0072299 |
1 |
0.043
|
|
|
|
response to amphetamine
|
GO:0001975 |
16 |
0.043
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.043
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.042
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.042
|
|
|
|
respiratory burst
|
GO:0045730 |
8 |
0.042
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.042
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.042
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.041
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.041
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.041
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.041
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.041
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.041
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.041
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.041
|
|
|
|
intestinal epithelial cell development
|
GO:0060576 |
12 |
0.041
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.040
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.040
|
|
|
|
viral transcription
|
GO:0019083 |
3 |
0.040
|
|
|
|
circadian behavior
|
GO:0048512 |
13 |
0.040
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.040
|
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.040
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.039
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.039
|
|
|
|
respiratory burst involved in defense response
|
GO:0002679 |
6 |
0.039
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.039
|
|
|
|
conditioned taste aversion
|
GO:0001661 |
4 |
0.039
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.039
|
|
|
|
positive regulation of nuclear transcribed mrna catabolic process deadenylation dependent decay
|
GO:1900153 |
5 |
0.039
|
Human |
|
|
fertilization
|
GO:0009566 |
127 |
0.039
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.038
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.038
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.038
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.038
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.038
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.037
|
|
|
|
regulation of peptidyl serine phosphorylation
|
GO:0033135 |
39 |
0.037
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.037
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.037
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.037
|
|
|
|
production of molecular mediator involved in inflammatory response
|
GO:0002532 |
21 |
0.036
|
|
|
|
macromolecule deacylation
|
GO:0098732 |
37 |
0.036
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.036
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.036
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.036
|
|
|
|
regulation of rho gtpase activity
|
GO:0032319 |
58 |
0.036
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.036
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.036
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.036
|
|
|
|
osteoblast proliferation
|
GO:0033687 |
18 |
0.036
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.036
|
|
|
|
epithalamus development
|
GO:0021538 |
2 |
0.035
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.035
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.035
|
|
|
|
brain segmentation
|
GO:0035284 |
3 |
0.035
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.035
|
|
|
|
cranial nerve morphogenesis
|
GO:0021602 |
26 |
0.035
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.035
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.035
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.034
|
|
|
|
negative regulation of viral transcription
|
GO:0032897 |
3 |
0.034
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.034
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.034
|
|
|
|
negative regulation of cell fate specification
|
GO:0009996 |
4 |
0.033
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.033
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.033
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.033
|
|
|
|
labyrinthine layer morphogenesis
|
GO:0060713 |
21 |
0.033
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.033
|
|
|
|
muscle hypertrophy
|
GO:0014896 |
24 |
0.033
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.033
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.033
|
|
|
|
proepicardium development
|
GO:0003342 |
2 |
0.033
|
|
|
|
negative regulation of response to biotic stimulus
|
GO:0002832 |
10 |
0.033
|
|
|
|
viral gene expression
|
GO:0019080 |
3 |
0.033
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.033
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.033
|
|
|
|
regulation of mrna catabolic process
|
GO:0061013 |
6 |
0.032
|
Human |
|
|
rhombomere 5 formation
|
GO:0021666 |
1 |
0.032
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.032
|
|
|
|
negative regulation of respiratory burst
|
GO:0060268 |
1 |
0.032
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.032
|
|
|
|
learning
|
GO:0007612 |
98 |
0.032
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.032
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.032
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.032
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.032
|
|
|
|
negative regulation of translation
|
GO:0017148 |
22 |
0.032
|
Human |
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.032
|
|
|
|
negative regulation of metanephric glomerular mesangial cell proliferation
|
GO:0072302 |
1 |
0.032
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.031
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.031
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.031
|
Human |
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.031
|
|
|
|
positive regulation of rhodopsin gene expression
|
GO:0045872 |
2 |
0.031
|
|
|
|
neuron maturation
|
GO:0042551 |
29 |
0.031
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.031
|
|
|
|
cellular response to metal ion
|
GO:0071248 |
31 |
0.031
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.031
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.031
|
|
|
|
heart growth
|
GO:0060419 |
45 |
0.031
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.031
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.031
|
|
|
|
regulation of cell migration involved in sprouting angiogenesis
|
GO:0090049 |
4 |
0.030
|
|
|
|
oligodendrocyte differentiation
|
GO:0048709 |
53 |
0.030
|
|
|
|
muscle hypertrophy in response to stress
|
GO:0003299 |
10 |
0.030
|
|
|
|
epidermis morphogenesis
|
GO:0048730 |
33 |
0.030
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.030
|
|
|
|
response to catecholamine
|
GO:0071869 |
4 |
0.030
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.030
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.030
|
|
|
|
regulation of protein sumoylation
|
GO:0033233 |
4 |
0.030
|
|
|
|
metanephric glomerular mesangium development
|
GO:0072223 |
3 |
0.030
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.030
|
|
|
|
response to corticosterone
|
GO:0051412 |
1 |
0.029
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.029
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.029
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.029
|
|
|
|
regulation of mesenchymal cell apoptotic process involved in metanephros development
|
GO:1900211 |
4 |
0.029
|
|
|
|
cranial nerve development
|
GO:0021545 |
41 |
0.029
|
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.029
|
|
|
|
mrna destabilization
|
GO:0061157 |
4 |
0.029
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.029
|
|
|
|
synapse assembly
|
GO:0007416 |
56 |
0.029
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.029
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.029
|
|
|
|
negative regulation of mesenchymal cell apoptotic process involved in metanephros development
|
GO:1900212 |
4 |
0.028
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.028
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.028
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.028
|
Human |
|
|
regulation of jun kinase activity
|
GO:0043506 |
40 |
0.028
|
|
|
|
apoptotic mitochondrial changes
|
GO:0008637 |
48 |
0.028
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.028
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.028
|
|
|
|
activation of mapkkk activity
|
GO:0000185 |
1 |
0.027
|
|
|
|
mitotic nuclear division
|
GO:0007067 |
48 |
0.027
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.027
|
|
|
|
sensory system development
|
GO:0048880 |
3 |
0.027
|
|
|
|
positive regulation of mrna processing
|
GO:0050685 |
16 |
0.027
|
Human |
|
|
type i pneumocyte differentiation
|
GO:0060509 |
7 |
0.027
|
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.027
|
|
|
|
regulation of cyclin dependent protein serine threonine kinase activity
|
GO:0000079 |
16 |
0.027
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.026
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.026
|
|
|
|
ceramide biosynthetic process
|
GO:0046513 |
20 |
0.026
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.026
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.026
|
|
|
|
cellular response to fluid shear stress
|
GO:0071498 |
4 |
0.026
|
|
|
|
striated muscle adaptation
|
GO:0014888 |
26 |
0.026
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.026
|
|
|
|
response to purine containing compound
|
GO:0014074 |
28 |
0.026
|
|
|
|
regulation of metanephric glomerular mesangial cell proliferation
|
GO:0072301 |
1 |
0.026
|
|
|
|
adipose tissue development
|
GO:0060612 |
25 |
0.026
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.026
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.026
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.026
|
|
|
|
cranial nerve formation
|
GO:0021603 |
4 |
0.026
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.026
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.026
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.026
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.025
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.025
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.025
|
|
|
|
regulation of osteoclast differentiation
|
GO:0045670 |
36 |
0.025
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.025
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.025
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.025
|
|
|
|
catecholamine metabolic process
|
GO:0006584 |
30 |
0.025
|
|
|
|
positive regulation of histone modification
|
GO:0031058 |
28 |
0.025
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.025
|
|
|
|
negative regulation of chemokine production
|
GO:0032682 |
4 |
0.025
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.025
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.025
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.025
|
|
|
|
regulation of peptidyl lysine acetylation
|
GO:2000756 |
22 |
0.024
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.024
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.024
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.024
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.024
|
|
|
|
regulation of cell projection assembly
|
GO:0060491 |
38 |
0.024
|
|
|
|
embryonic placenta morphogenesis
|
GO:0060669 |
25 |
0.024
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.024
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.024
|
|
|
|
gene silencing by rna
|
GO:0031047 |
19 |
0.024
|
|
|
|
zygotic determination of anterior posterior axis embryo
|
GO:0007354 |
3 |
0.024
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.024
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.024
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.023
|
|
|
|
regulation of protein deacetylation
|
GO:0090311 |
17 |
0.023
|
|
|
|
negative regulation of cysteine type endopeptidase activity
|
GO:2000117 |
22 |
0.023
|
|
